A comprehensive view of moderna inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

COVID-19 vaccine makers prepare for smaller booster vaccine market as demand for first shots falls; global booster shot market, including people over 50, adults with health risk factors or who work in high-risk occupations, estimated at 1.7 billion people

Commentary: mRNA technology used by Pfizer, Moderna for COVID vaccines could end up unlocking much more for future of health care; numerous mRNA vaccine candidates are being researched, undergoing clinical trials for treating cancer, HIV, flu, ebola, more

Moderna reports Q1 net profit up at US$3.7B from US$1.2B a year ago, with total revenue up at US$6.1B from US$1.9B a year ago, as COVID-19 vaccine sales jump to US$5.9B from US$1.7B a year ago; bivalent COVID-19 booster vaccine currently in Phase2/3 study

Moderna to build vaccine production facility in Montreal, Quebec, to open in 2024 as part of Canadian government’s billion dollar investment to rebuild vaccine production in the country; Moderna also building vaccine plant in Melbourne, Australia

Moderna request emergency use authorization in US for its COVID-19 vaccination for kids aged six months to six years in two 25 mg doses, with Moderna aiming for June vaccine roll-out; children under five have very low risk of developing severe disease

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count